Edition:
United States

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

1,006.00INR
6:29am EDT
Change (% chg)

Rs14.30 (+1.44%)
Prev Close
Rs991.70
Open
Rs995.00
Day's High
Rs1,012.40
Day's Low
Rs993.00
Volume
1,967,659
Avg. Vol
1,983,772
52-wk High
Rs1,573.60
52-wk Low
Rs917.55

Chart for

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: -0.02
Market Cap(Mil.): Rs448,087.91
Shares Outstanding(Mil.): 451.84
Dividend: 7.50
Yield (%): 0.76

Financials

  Industry Sector
P/E (TTM): -- 31.24 15.93
EPS (TTM): -- -- --
ROI: -- 15.06 14.60
ROE: -- 16.31 13.96

BRIEF-Lupin gets FDA nod for generic inflammatory skin disorder treatment

* Gets FDA nod for generic treatment, clobetasol propionate lotion‍​, to treat a type of inflammatory skin disorder Source text: http://bit.ly/2xEcWE4 Further company coverage:

Sep 25 2017

BRIEF-India's Lupin gets FDA nod for generic flagyl tablets

* Says Lupin receives FDA approval for generic flagyl tablets

Sep 13 2017

BRIEF-India's Lupin gets U.S. FDA approval for generic vibra-tabs tablet

* Says Lupin receives FDA approval for generic vibra-tabs tablet

Sep 11 2017

BRIEF-Lupin launches generic benicar tablets in the U.S.

* Says lupin launches generic benicar tablets in the U.S. Source text - http://bit.ly/2vXYmmI Further company coverage:

Sep 04 2017

BRIEF-India's Lupin launches generic fosrenol chewable tablets in the U.S.

Aug 31 Lupin Ltd * Launches generic fosrenol chewable tablets in the US Source text - http://bit.ly/2vLFaZ0 Further company coverage:

Aug 31 2017

BRIEF-Lupin launches generic Seroquel tablets in U.S.‍​

* Says drug used for treatment of schizophrenia, acute manic or mixed episodes in bipolar i disorder‍​ Source text: http://bit.ly/2wndJsS Further company coverage:

Aug 23 2017

BRIEF-Lupin gets EIR from U.S. FDA for Aurangabad inspection

* Says receives EIR from U.S. FDA for Aurangabad, April 2017 inspection

Aug 21 2017

BRIEF-Natco Pharma says co, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

* Says Natco, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

Aug 14 2017

UPDATE 2-India's Sun Pharma reports Q1 loss as generics business suffers

* Expects profit margin to improve in second-half of 2018 (Adds Managing Director comments from conference call)

Aug 11 2017

BRIEF-Lupin appoints Manju Deshbandhu Gupta as chairman

* Says appoints Manju Deshbandhu Gupta as chairman Source text - http://bit.ly/2vLkapj Further company coverage:

Aug 11 2017

Earnings vs. Estimates